Dornan et al. reported a substantial dynamic range in CD79b expression on the cell surface of DLBCL cell lines, identifying a threshold effect where cases below a specific level of antigen expression exhibited insensitivity to the maximum amount of anti-CD79b-vcMMAE tested [13]. Here, CD79B is linked to diffuse large B-cell lymphoma.